CSI Market
Sign In | Register

Ultragenyx Pharmaceutical Inc (RARE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RARE Annual Balance Sheets →
A period-by-period view of the balance sheet from Ultragenyx Pharmaceutical Inc to Sep 30 2025 helps clarify how Sep 30 2026's financial structure has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/RARE/balance-sheets
https://api.csimarket.com/api/v1/companies/RARE/fundamentals
https://api.csimarket.com/api/v1/companies/RARE/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent150.00
Restricted Cash8.00
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments150.00
Accounts receivable166.00
Inventories59.00
Prepaid Expense And Other Assets Current53.00
Total Current Assets544.00
Equipment/Property/Plant Net231.00
Goodwill net44.00
Intangible Assets170.00
Long-term investments135.00
Other Assets, Noncurrent171.00
Total Assets1,187.00
Liabilities
Accounts Payable, Current AC45.00
Accrued Liabilities, Current AC242.00
Other Liabilities, Current102.00
Total Current Liabilities389.00
Total Long-term Debt0.00
Other liabilities, Noncurrent1,167.00
Operating Lease Liability Current-
Liabilities For Sales Of Future Royalties Current72.00
Operating Lease Liability Noncurrent-
Liability Related To Sale Of Future Royalties1,128.00
Total Liabilities1,556.00
Stockholders' Equity
Common Stock Value0.00
Treasury Stock Value-10.00
Additional Paid In Capital Common Stock4,552.00
Retained Earnings / Accumulated Deficit-4,927.00
Accumulated Other Comprehensive Income-1.00
Other Equity-1.00
Common Stockholder's Equity-383.00
Non-controlling interests & other7.00
Total Stockholder's Equity-376.00
Liabilities & Stockholder's Equity1,187.00
4 historic quarters locked

Sign in to unlock the full Ultragenyx Pharmaceutical Inc balance sheet history.

Sign In Create Free Account

About Ultragenyx Pharmaceutical Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-445718

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI